China's struggle for practical regulations in medical ethics

被引:18
作者
Döring, O [1 ]
机构
[1] Ruhr Univ Bochum, Fac E Asian Studies, Chinese Hist & Philosophy Dept, D-44780 Bochum, Germany
关键词
D O I
10.1038/nrg1022
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
The introduction of ethical regulations in medicine in China might seem at odds with the country's social and moral reality. Chinese bioethicists find themselves torn between the necessity to re-create a fully-fledged modern health-care system and aspirations to become global players in the biomedical sciences. The result is a top-down approach in medical ethics, created on behalf of the people. Despite its introduction, there are concerns about whether China is prepared to embrace the standards it claims to have adopted.
引用
收藏
页码:233 / 239
页数:7
相关论文
共 60 条
[1]   China plans 'hybrid' embryonic stem cells [J].
Abbott, A ;
Cyranoski, D .
NATURE, 2001, 413 (6854) :339-339
[2]  
[Anonymous], 1998, PROP INT GUID ETH IS
[3]  
[Anonymous], WASHINGTON POST 1220
[4]  
[Anonymous], NEW SCI 1024
[5]  
[Anonymous], FORMOSA J MED HUMANI
[6]   REDRAFTED CHINESE LAW REMAINS EUGENE [J].
BOBROW, M .
JOURNAL OF MEDICAL GENETICS, 1995, 32 (06) :409-409
[7]  
BOESCHEN M, 2001, FINANCIAL TIMES 0716, P25
[8]  
CHEN RB, 2002, MITTEILUNGEN I ASIEN, V355, P12
[9]  
CHEN RX, 2002, MITTEILUNGEN I ASIEN, V355, P214
[10]   A great leap forward [J].
Cyranoski, D .
NATURE, 2001, 410 (6824) :10-12